Evidence map›Paper›PMID 26076477›Full record

ArticlePloS one2015

Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response.

Christoph Schell, Oliver Kretz, Andreas Bregenzer, Manuel Rogg, Martin Helmstädter, Ulrike Lisewski, Michael Gotthardt, Pierre-Louis Tharaux, Tobias B Huber, Florian Grahammer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Christoph SchellRenal Division, University Medical Center Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs University Freiburg, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs University Freiburg, Freiburg, Germany.
Oliver KretzRenal Division, University Medical Center Freiburg, Freiburg, Germany; Department of Neuroanatomy, Albert-Ludwigs University Freiburg, Freiburg, Germany.
Andreas BregenzerRenal Division, University Medical Center Freiburg, Freiburg, Germany.
Manuel RoggRenal Division, University Medical Center Freiburg, Freiburg, Germany.
Martin HelmstädterRenal Division, University Medical Center Freiburg, Freiburg, Germany.
Ulrike LisewskiMax-Delbrueck Center for Molecular Medicine, Berlin, Germany.
Michael GotthardtMax-Delbrueck Center for Molecular Medicine, Berlin, Germany.
Pierre-Louis TharauxParis Centre de Recherche Cardiovasculaire, INSERM, Paris, France.
Tobias B HuberRenal Division, University Medical Center Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs University Freiburg, Freiburg, Germany; BIOSS Center for Biological Signaling Studies, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Florian GrahammerRenal Division, University Medical Center Freiburg, Freiburg, Germany.
University Medical Center Freiburg · DEMax Delbrück Center · DEInserm · FRUniversity of Freiburg · DE

Funding

European Research Council 616891
6 · The paper itself

Abstract

The coxsackie- and adenovirus receptor (CXADR) is a member of the immunoglobulin protein superfamily, present in various epithelial cells including glomerular epithelial cells. Beside its known function as a virus receptor, it also constitutes an integral part of cell-junctions. Previous studies in the zebrafish pronephros postulated a potential role of CXADR for the terminal differentiation of glomerular podocytes and correct patterning of the elaborated foot process architecture. However, due to early embryonic lethality of constitutive Cxadr knockout mice, mammalian data on kidney epithelial cells have been lacking. Interestingly, Cxadr is robustly expressed during podocyte development and in adulthood in response to glomerular injury. We therefore used a conditional transgenic approach to elucidate the function of Cxadr for podocyte development and stress response. Surprisingly, we could not discern a developmental phenotype in podocyte specific Cxadr knock-out mice. In addition, despite a significant up regulation of CXADR during toxic, genetic and immunologic podocyte injury, we could not detect any impact of Cxadr on these injury models. Thus these data indicate that in contrast to lower vertebrate models, mammalian podocytes have acquired molecular programs to compensate for the loss of Cxadr.

Indexed as

Gene DeletionStress, PhysiologicalAnimalsCoxsackie and Adenovirus Receptor-Like Membrane ProteinGene ExpressionGene Knockout TechniquesKidneyKidney GlomerulusMiceMice, KnockoutPodocytesCLMP protein, mouseCoxsackie and Adenovirus Receptor-Like Membrane Protein

Identifiers

PMID26076477
PMCPMC4468136
OpenAlexW560622854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.